글로벌 지카 바이러스 감염 약물 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 지카 바이러스 감염 약물 시장

지카 바이러스 감염 약물 시장은 2021년에서 2028년까지의 예측 기간 동안 5.70%의 시장 성장을 목격할 것으로 예상됩니다. 지카 바이러스 감염 약물 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 지카 바이러스 질병의 발생률 증가는 지카 바이러스 감염 약물 시장의 성장을 가속화하고 있습니다.

지카 바이러스 질병은 주로 낮에 흡혈하는 이집트숲모기에 의해 전파되는 바이러스로 인한 질병이라고 할 수 있습니다. 또한 감염된 개인과의 성적 접촉이나 감염된 임산부를 통해 태아에게 전파됩니다.

예측 기간 동안 지카 바이러스 감염 약물 시장 성장을 촉진할 것으로 예상되는 주요 요인은 지카 바이러스 감염에 대한 혈청학적 검사 개발의 증가입니다. 또한, 주요 제약 회사 가 새로운 백신을 개발하기 위해 연구 개발에 투자하는 것이 증가함에 따라 지카 바이러스 감염 약물 시장 성장이 더욱 촉진될 것으로 예상됩니다. 또한, 백신 개발을 위한 경계 프로그램과 협력 연구의 증가는 지카 바이러스 감염 약물 시장 성장을 더욱 완화할 것으로 추산됩니다. 반면에 지카 감염 발생률이 낮아 효율적인 치료를 받을 수 없는 경우 향후 몇 년 동안 지카 바이러스 감염 약물 시장 성장이 더욱 저해될 것으로 예상됩니다.

In addition, the need of novel therapies for treating the Zika virus infections will further provide potential opportunities for the growth of the zika virus infection drug market will further provide potential opportunities for the growth of the zika virus infection drug market in the coming years. However, the absence of alertness regarding the clinical advancement and the novel therapies for Zika infection treatment might further challenge the growth of the zika virus infection drug market in the near future.The zika virus infection drug market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the zika virus infection drug market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Zika Virus Infection Drug Market Scope and Market Size

The zika virus infection drug market is segmented on the basis of strains type, treatment type, drugs, route of administration and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of strains type, the zika virus infection drug market is segmented into aedes aegypti, aedes albopictus.
• On the basis of treatment type, the zika virus infection drug market is segmented into preventive treatment, symptomatic treatment and others.
• On the basis of drugs, the zika virus infection drug market is segmented into chloroquine, daptomycin and others.
• On the basis of route of administration, the zika virus infection drug market is segmented into oral, injectable.
• On the basis of end users, the zika virus infection drug market is segmented into hospitals, homecare, specialty clinics, and others.

Zika Virus Infection Drug Market Country Level Analysis

The zika virus infection drug market is analysed and market size information is provided by country, strains type, treatment type, drugs, route of administration and end users as referenced above.

The countries covered in the zika virus infection drug market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Latin America dominates the zika virus infection drug market due to the rise in the Zika virus disease. Furthermore, the maximum number of infected people will further boost the growth of the zika virus infection drug market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the zika virus infection drug market due to the rise in the incidence of mosquito-borne illness.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The zika virus infection drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Zika Virus Infection Drug Market Share Analysis

The zika virus infection drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to zika virus infection drug market.

지카 바이러스 감염 약물 시장 보고서에서 다루는 주요 업체는 Emergent BioSolutions Inc, Valneva SE, Moderna, Inc, Novavax, Inc, Johnson & Johnson Private Limited, Themis Bioscience GmbH, Sanofi, IMV Inc., Takeda Pharmaceutical Company Limited, Carogen Corporation, GeoVax, Tychan Pte. Ltd, WuXi Biologics, Inovio Pharmaceuticals, Inc, GeneOne Life Science, Hawaii Biotech, Inc., BIOCRYST PHARMACEUTICALS, INC., Imutex Limited, Bharat Biotech, GlaxoSmithKline Plc. 등 국내 및 글로벌 업체입니다. 지카 바이러스 감염 약물 시장 점유율 데이터는 글로벌, 북미, 남미, 유럽, 아시아 태평양(APAC) 및 중동 및 아프리카(MEA)에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-46116